ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 406 filers reported holding ENCOMPASS HEALTH CORP in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,578,683 | -1.0% | 127,735 | -0.1% | 0.13% | 0.0% |
Q2 2023 | $8,661,599 | +25.4% | 127,922 | +0.2% | 0.13% | +20.0% |
Q1 2023 | $6,907,488 | +87005.8% | 127,680 | -3.7% | 0.10% | -15.3% |
Q4 2022 | $7,930 | -99.9% | 132,584 | -0.4% | 0.12% | +22.8% |
Q3 2022 | $6,020,000 | -7.6% | 133,091 | +14.5% | 0.10% | -1.0% |
Q2 2022 | $6,513,000 | -20.7% | 116,193 | +0.7% | 0.10% | -12.8% |
Q1 2022 | $8,208,000 | +8.7% | 115,421 | -0.2% | 0.12% | +18.2% |
Q4 2021 | $7,548,000 | -12.4% | 115,665 | +0.7% | 0.10% | -16.8% |
Q3 2021 | $8,615,000 | +15.4% | 114,808 | +20.0% | 0.12% | +17.8% |
Q2 2021 | $7,463,000 | +15.2% | 95,648 | +20.9% | 0.10% | +12.2% |
Q1 2021 | $6,478,000 | +6.7% | 79,094 | +7.7% | 0.09% | +1.1% |
Q4 2020 | $6,073,000 | -16.1% | 73,448 | -34.1% | 0.09% | -26.4% |
Q3 2020 | $7,237,000 | +3.7% | 111,375 | -1.1% | 0.12% | -0.8% |
Q2 2020 | $6,977,000 | -3.1% | 112,664 | +0.2% | 0.12% | -17.6% |
Q1 2020 | $7,199,000 | -39.7% | 112,429 | -34.7% | 0.15% | -19.1% |
Q4 2019 | $11,935,000 | – | 172,295 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
RK Capital | 179,800 | $13,492,000 | 2.55% |
Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |